Dietary factors and supplements influencing prostate specific-antigen (PSA) concentrations in men with prostate cancer and increased cancer risk: An evidence analysis review based on randomized controlled trials
dc.creator | Grammatikopoulou M.G., Gkiouras K., Papageorgiou S.Τ., Myrogiannis I., Mykoniatis I., Papamitsou T., Bogdanos D.P., Goulis D.G. | en |
dc.date.accessioned | 2023-01-31T07:44:34Z | |
dc.date.available | 2023-01-31T07:44:34Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.3390/nu12102985 | |
dc.identifier.issn | 20726643 | |
dc.identifier.uri | http://hdl.handle.net/11615/72715 | |
dc.description.abstract | The quest for dietary patterns and supplements efficient in down-regulating prostate-specific antigen (PSA) concentrations among men with prostate cancer (PCa) or increased PCa risk has been long. Several antioxidants, including lycopene, selenium, curcumin, coenzyme Q10, phytoestrogens (including isoflavones and flavonoids), green tea catechins, cernitin, vitamins (C, E, D) and multivitamins, medicinal mushrooms (Ganoderma lucidum), fruit extracts (saw palmetto, cranberries, pomegranate), walnuts and fatty acids, as well as combined supplementations of all, have been examined in randomized controlled trials (RCTs) in humans, on the primary, secondary, and tertiary PCa prevention level. Despite the plethora of trials and the variety of examined interventions, the evidence supporting the efficacy of most dietary factors appears inadequate to recommend their use. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | en |
dc.language.iso | en | en |
dc.source | Nutrients | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091797979&doi=10.3390%2fnu12102985&partnerID=40&md5=ef65c80af9ff32c59af352357b1213e1 | |
dc.subject | alpha tocopherol | en |
dc.subject | antioxidant | en |
dc.subject | ascorbic acid | en |
dc.subject | catechol derivative | en |
dc.subject | curcumin | en |
dc.subject | fatty acid | en |
dc.subject | lycopene | en |
dc.subject | nutraceutical | en |
dc.subject | phytoestrogen | en |
dc.subject | plant extract | en |
dc.subject | prostate specific antigen | en |
dc.subject | selenium | en |
dc.subject | vitamin D | en |
dc.subject | antioxidant | en |
dc.subject | catechin | en |
dc.subject | phytoestrogen | en |
dc.subject | prostate specific antigen | en |
dc.subject | vitamin | en |
dc.subject | antigen blood level | en |
dc.subject | Article | en |
dc.subject | cancer risk | en |
dc.subject | clinical effectiveness | en |
dc.subject | cranberry | en |
dc.subject | diet supplementation | en |
dc.subject | diet therapy | en |
dc.subject | dietary pattern | en |
dc.subject | grape | en |
dc.subject | human | en |
dc.subject | medicinal mushroom | en |
dc.subject | obesity | en |
dc.subject | pomegranate | en |
dc.subject | prostate cancer | en |
dc.subject | prostate hypertrophy | en |
dc.subject | randomized controlled trial (topic) | en |
dc.subject | Sabal | en |
dc.subject | tea | en |
dc.subject | adult | en |
dc.subject | adverse event | en |
dc.subject | aged | en |
dc.subject | blood | en |
dc.subject | diet | en |
dc.subject | dietary supplement | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | phytotherapy | en |
dc.subject | procedures | en |
dc.subject | prostate tumor | en |
dc.subject | risk factor | en |
dc.subject | treatment outcome | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Antioxidants | en |
dc.subject | Catechin | en |
dc.subject | Diet | en |
dc.subject | Dietary Supplements | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Phytoestrogens | en |
dc.subject | Phytotherapy | en |
dc.subject | Prostate-Specific Antigen | en |
dc.subject | Prostatic Neoplasms | en |
dc.subject | Randomized Controlled Trials as Topic | en |
dc.subject | Risk Factors | en |
dc.subject | Treatment Outcome | en |
dc.subject | Vitamins | en |
dc.subject | MDPI AG | en |
dc.title | Dietary factors and supplements influencing prostate specific-antigen (PSA) concentrations in men with prostate cancer and increased cancer risk: An evidence analysis review based on randomized controlled trials | en |
dc.type | journalArticle | en |
Αρχεία σε αυτό το τεκμήριο
Αρχεία | Μέγεθος | Τύπος | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |